Amanote Research
Register
Sign In
Light-Trigerred Cellular Epigenetic Molecule Release to Reverse Tumor Multidrug Resistance
doi 10.1021/acs.bioconjchem.8b00073.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
The Tumor Suppressor ING1 Contributes to Epigenetic Control of Cellular Senescence
Aging Cell
Aging
Cell Biology
Crown Ethers Reverse P-Glycoprotein-Mediated Multidrug Resistance in Cancer Cells
Scientific Reports
Multidisciplinary
Codelivery of Chemotherapeutics via Crosslinked Multilamellar Liposomal Vesicles to Overcome Multidrug Resistance in Tumor
PLoS ONE
Multidisciplinary
Staurosporine Derivatives Reverse Multidrug Resistance Without Correlation With Their Protein Kinase Inhibitory Activities.
Journal of Antibiotics
Drug Discovery
Pharmacology
Overcoming Multidrug Resistance of Small-Molecule Therapeutics Through Conjugation With Releasable Octaarginine Transporters
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Polysaccharide-Based Nanoparticles for Co-Loading Mitoxantrone and Verapamil to Overcome Multidrug Resistance in Breast Tumor
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
A Simple Reduction-Sensitive Micelles Co-Delivery of Paclitaxel and Dasatinib to Overcome Tumor Multidrug Resistance
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
Engineering Cellular Resistance to HIV
New England Journal of Medicine
Medicine
The Antiherpetic Drug Acyclovir Inhibits HIV Replication and Selects the V75I Reverse Transcriptase Multidrug Resistance Mutation
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
